Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 30 Dec 2001):
Free Full Text!
See links below

Pharmacological applications of magnetic resonance imaging.

Full Abstract

Magnetic resonance imaging (MRI) techniques are capable of spatial and temporal resolution and within subject repeatability that far exceed other currently available methods of noninvasively investigating brain functioning. While functional MRI (fMRI) techniques have traditionally been used to investigate sensory, motor, and cognitive functions, they are also very attractive for investigating the effects of pharmacological agents in the brain. However, because pharmacological agents may interfere with the very mechanisms that give rise to the fMRI signal, careful attention to experimental design and data analysis issues must be exercised. Specifically, introducing a drug into the system could potentially alter the coupling of neural activity with regional cerebral blood flow and/or the extraction of oxygen from blood, or may cause local or global cardiovascular changes unrelated to neural activity. These concerns notwithstanding, careful attention to experimental detail and verification procedures promises to make pharmacological MRI a valuable tool for understanding the actions of drugs on the brain at many levels. The physiological and biophysical bases of blood oxygen level-dependent, arterial spin labeling, cerebral blood flow, cerebral blood volume, and spectroscopy acquisition methods are presented to illustrate where confounds may arise when a drug is added to the system. Selected studies combining administration of pharmacological agents with MRI techniques are critically reviewed to illustrate both the challenges inherent in these applications and some possible solutions. Included are studies of acute direct effects of drugs, effects of drugs on task-related activation, chronic effects of drugs, effects of drugs on cerebral metabolism, and variable effects of drugs in different populations.

 

Learn Faster Today      Improve your study skills

Author information

Author/s: Salmeron, Betty Jo (BJ); Stein, Elliot A (EA);

Affiliation: Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee, USA.

Grants: DA09465 (Agency:NIDA NIH HHS) ; DA10214 (Agency:NIDA NIH HHS) ; M05 RR00058 (Agency:NCRR NIH HHS)

Journal and publication information

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review

Journal: Psychopharmacology bulletin (Psychopharmacol Bull), published in United States. (Language: eng)

Reference: 2002-; vol 36 (issue 1) : pp 102-29

Dates: Created 2002/10/25; Completed 2002/11/19; Revised 2007/11/14;

PMID: 12397851, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Oxygen (7782-44-7)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

12/30/1983
6/29/2004
Higher Relevance Score (8)
Lower Relevance Score (6)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy.com 2003-2009 (ACN 104 198 263) - All rights reserved. Terms of Use | Contact Us | Index